President Donald Trump signed an executive order on Monday that directs federal agencies to conduct research and draft reports regarding childhood vaccine recommendations. During an Oval Office ceremony, the president stated that the move aims to establish a "gold standard" for vaccine schedules. While the order calls for the exploration of splitting combined vaccines into individual doses, it does not implement immediate changes to the current immunization requirements or the availability of shots.
The order follows previous attempts by the administration to modify the federally recommended vaccine schedule for children. In March 2026, a court blocked an effort to reduce the number of recommended vaccines. Following that ruling, the administration sought to change the timing and list of shots through an advisory panel, but those efforts did not take effect. This latest executive action occurs as many students begin the school year and ahead of the November midterm elections.
The executive order specifically requests the development of separate shots for measles, mumps, and rubella, which are currently administered as a single combined MMR vaccine. Currently, separate versions of these vaccines are not available in the United States. A White House official stated that the administration will work with private pharmaceutical companies to investigate the feasibility of producing individual doses. Additionally, President Trump and Health Secretary Robert F. Kennedy Jr. spoke at the signing about potential links between vaccines and autism, though medical studies cited by the CDC have debunked such a connection.
The scale of the impact is currently limited by state-level authority and existing insurance contracts. In 45 states, parents already have the right to seek medical or non-medical exemptions, and states—not the federal government—set the requirements for school entry. However, public health experts like Jen Kates of KFF note that even small shifts in vaccine coverage can lead to breakthrough infections, such as measles outbreaks. A move to split the MMR vaccine would increase the number of injections a child receives from one shot to three to achieve the same level of immunity, potentially increasing time off work for parents and total healthcare visits.
What happens next depends on the reports generated by the executive order and the response from private drug manufacturers. There is no set date for when individual measles, mumps, or rubella shots might become available, as they are not currently manufactured for the U.S. market. For now, pediatricians report that all shots on the American Academy of Pediatrics' backed schedule remain available and covered by insurance. The administration has not provided a specific deadline for the research requested in the order, and further changes may face legal challenges similar to those that blocked the administration's March 2026 vaccine policy.